The Ministry of Health, through the Pharmacy and Poisons Board (PPB), has warned against the importation and sale of unregistered health products in Kenya, particularly those referencing the Indian Pharmacopoeia (IP).
In a statement released on Friday, the board's Chief Executive Officer, Fred Siyoi, highlighted growing concerns over the influx of such products into the local market.
The Indian Pharmacopoeia, a set of standards used to regulate drugs in India, sets quality, safety, and efficacy requirements for medicines sold within the country.
However, according to the PPB, these standards are not applicable in Kenya.
